Senna
NDC 54162-007
Product Information
Senna is a OTC MONOGRAPH NOT FINAL-approved product labeled by Geritrex Llc. Sennosides are used to treat constipation. It is supplied as a product. This product entry covers the primary NDC 54162-007 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 54162-007?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- SENNOSIDES A AND B (UNII: 1B5FPI42EN)
- SENNOSIDES A AND B (UNII: 1B5FPI42EN) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- METHYLPARABEN (UNII: A2I8C7HI9T)
- ISOPROPYLPARABEN (UNII: A6EOX47QK0)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- SUCROSE (UNII: C151H8M554)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 702311 - sennosides 8.8 MG in 5 mL Oral Solution
- RxCUI: 702311 - sennosides, USP 1.76 MG/ML Oral Solution
- RxCUI: 702311 - sennosides 8.8 MG per 5 mL Oral Syrup
- RxCUI: 702311 - sennosides, USP 26.4 MG per 15 ML Oral Solution
- RxCUI: 702311 - sennosides, USP 8.8 MG per 5 ML Oral Solution
* Please review the full disclaimer at the bottom of this page.